- Net Income: Rongsheng Petro earned 857.9 million yuan in the first half of 2024.
- Revenue: The company generated 161.25 billion yuan in revenue during this period.
- Earnings Per Share (EPS): Earnings were reported at 9.0 RMB cents per share.
- Analyst Recommendations:
- 21 analysts recommend buying the stock.
- 0 analysts recommend holding the stock.
- 1 analyst recommends selling the stock.
A look at Rongsheng Petro Chemical A Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 3 | |
Dividend | 3 | |
Growth | 3 | |
Resilience | 2 | |
Momentum | 3 | |
OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on analysis using the Smartkarma Smart Scores, Rongsheng Petro Chemical A shows a balanced long-term outlook across key factors. The company receives moderate scores in categories such as Value, Dividend, Growth, and Momentum, indicating a steady performance in these areas. However, its Resilience score is slightly lower, suggesting some vulnerability to market fluctuations. Rongsheng Petro Chemical A‘s focus on manufacturing and selling purified terephthalic acid (PTA) and polyester yarn products positions it within the sector despite varied scores across different metrics.
Rongsheng Petro Chemical A‘s Smart Scores paint a picture of stability with room for improvement in sustainability and market resilience. With an average rating across Value, Dividend, Growth, and Momentum, the company showcases a consistent performance outlook. Its slightly lower Resilience score implies a need for strategic adjustments to navigate market challenges effectively. Specializing in PTA and various polyester yarn products, Rongsheng Petro Chemical’s position in the market remains solid, with the potential for further growth and development in the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars